Surmodics reported $20.07M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Align Technology ALGN:US $ 877.5M 48.62M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Baxter International BAX:US $ 1852M 442M
Bioscrip BIOS:US $ 204.05M 58.45M
Cryolife CRY:US $ 40.38M 11.03M
Edap Tms EDAP:US $ 48.57M 2.88M
Edwards Lifesciences EW:US $ 1198.1M 167.2M
Haemonetics HAE:US $ 214.95M 44.55M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Merit Medical Systems MMSI:US $ 63M 9.13M
Mesa Laboratories MLAB:US $ 43.75M 5.6M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Stryker SYK:US $ 1044M 414M
Surmodics SRDX:US $ 20.07M 4.64M
Trinity Biotech TRIB:US $ 10.01M 15.9M